Ocular Therapeutix OCUL Q1 2026 Disappoints EPS 040 Below 032 Views CNBC Disruptor 50 2026 Anthropic Tops the List as AI Race Intensifies Willdan Group WLDN Q1 2026 Earnings Why the Beat Matters Minerva Neurosciences NERV Slides 522 as Selling Pressure Mounts 20260515 THRY Q1 2026 Earnings Significant EPS Beat Surprises Market VICI Q1 2026 Earnings Strong EPS Surprise of 1443 Despite Flat Stock Reaction NEWP Q1 2026 Earnings Widerthanexpected loss highlights exploration spending pressures AIRO Q4 2025 Earnings Significant EPS Miss Beyond Expectations Stock Rises American Shared Hospital Services Q1 2026 Earnings Significant EPS Miss as Losses Deepen Digi Power X Inc DGXX Q3 2025 Earnings Losses Narrow as Operational Focus Intensifies